| Filed On | Filing |
|---|---|
| 29 Oct 2026 |
8-K: Results of Operations and Financial Condition
Refer to: Megan MacCauley; [email protected] (Media) |
| 05 Aug 2026 |
8-K: Results of Operations and Financial Condition
Refer to: Megan MacCauley; [email protected] (Media) |
| 20 May 2026 |
8-K: Other Events
Eli Lilly and Company, an Indiana corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $... |
| 07 May 2026 |
8-K: Submission of Matters to a Vote of Security Holders
The Eli Lilly and Company (the “Company”) annual meeting of shareholders (the “2026 Annual Meeting”) was held on May 4, 2026. The total number of shares of the Company's common stock voted in person or by proxy at the 2026 Annual Meeting... |
| 30 Apr 2026 |
8-K: Results of Operations and Financial Condition
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media) |
| 04 Feb 2026 |
8-K: Results of Operations and Financial Condition
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media) |
| 21 Nov 2025 |
8-K: Departure/Election of Directors or Officers; Compensation
On November 18, 2025, the Board of Directors (the “Board”) of Eli Lilly and Company (the “Company”) elected Carolyn R. Bertozzi, Ph.D as a new member of the Board, effective December 8, 2025. |
| 30 Oct 2025 |
8-K: Results of Operations and Financial Condition
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media) |
| 20 Aug 2025 |
8-K: Other Events
Eli Lilly and Company, an Indiana corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $... |
| 07 Aug 2025 |
8-K: Results of Operations and Financial Condition
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media) |
| 08 May 2025 |
8-K: Submission of Matters to a Vote of Security Holders
The Eli Lilly and Company (the “Company”) annual meeting of shareholders (the “2025 Annual Meeting”) was held on May 5, 2025. The total number of shares of the Company's common stock voted in person or by proxy at the 2025 Annual Meeting... |
| 01 May 2025 |
8-K: Results of Operations and Financial Condition
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media) |
| 12 Feb 2025 |
8-K: Other Events
Eli Lilly and Company, an Indiana corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $... |
| 06 Feb 2025 |
8-K: Results of Operations and Financial Condition
Refer to: Ashley Hennessey; [email protected]; (317) 416-4363 (Media) |
| 14 Jan 2025 |
8-K: Results of Operations and Financial Condition
Refer to: Carrie Munk; [email protected]; 317-416-2393 (Media) |
| 19 Nov 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
Refer to: Carrie Munk; [email protected]; 317-416-2393 (Media) |
| 30 Oct 2024 |
8-K: Results of Operations and Financial Condition
Refer to: Jordan Bishop; [email protected]; (317) 374-1878 (Media) |
| 09 Sep 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
Refer to: Jordan Bishop; [email protected]; (317) 473-5712 (Media) Joe Fletcher; [email protected]; (317) 296-2884 (Investors) |
| 16 Aug 2024 |
8-K: Departure/Election of Directors or Officers; Compensation
For Release: ImmediatelyRefer to: Jordan Bishop; [email protected]; 317-374-1878 (Media) |
| 14 Aug 2024 |
8-K: Other Events
Eli Lilly and Company, an Indiana corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $... |
Loading...